Steven Payne
Insider
First SEC filing: June 11, 2013 · Latest: June 11, 2013
Insider at
Insider transactions
0 buys (P)
0 sells (S)
Net: $0
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| Feb. 1, 2019 | GMED | A | 7,500 | · | · | 7,500 Direct | · | Acquired | (price as of 2026-10-05) |
| Sept. 26, 2018 | GMED | M | 3,000 | · | · | 0 Direct | -100.00% | Disposed | (price as of 2026-10-05) |
| Sept. 26, 2018 | GMED | S 10b5-1 | 3,000 | $56.00 | $168,000 | 0 Direct | -100.00% | Disposed | 35.3% (price as of 2026-10-05) |
| Sept. 26, 2018 | GMED | M | 3,000 | $12.59 | $37,770 | 3,000 Direct | · | Acquired | 501.7% (price as of 2026-10-05) |
| May 31, 2018 | GMED | S | 20,771 | $55.81 | $1,159,230 | 0 Direct | -100.00% | Disposed | 35.7% (price as of 2026-10-05) |
| Jan. 22, 2018 | GMED | A | 7,500 | · | · | 7,500 Direct | · | Acquired | (price as of 2026-10-05) |
| Dec. 15, 2017 | GMED | M | 3,076 | · | · | 0 Direct | -100.00% | Disposed | (price as of 2026-10-05) |
| Dec. 15, 2017 | GMED | S | 3,076 | $39.30 | $120,887 | 20,771 Direct | -12.90% | Disposed | 92.8% (price as of 2026-10-05) |
| Dec. 15, 2017 | GMED | M | 3,076 | $4.88 | $15,011 | 23,847 Direct | +14.81% | Acquired | 1452.5% (price as of 2026-10-05) |
| Jan. 30, 2017 | GMED | A | 7,500 | · | · | 7,500 Direct | · | Acquired | (price as of 2026-10-05) |
| May 28, 2015 | GMED | M | 3,076 | · | · | 0 Direct | -100.00% | Disposed | (price as of 2026-10-05) |
| May 28, 2015 | GMED | S | 3,076 | $25.92 | $79,730 | 20,771 Direct | -12.90% | Disposed | 192.3% (price as of 2026-10-05) |
| May 28, 2015 | GMED | M | 3,076 | $11.87 | $36,512 | 23,847 Direct | +14.81% | Acquired | 538.2% (price as of 2026-10-05) |
| Jan. 20, 2015 | GMED | A | 22,500 | · | · | 22,500 Direct | · | Acquired | (price as of 2026-10-05) |
| Feb. 20, 2014 | GMED | A | 7,500 | · | · | 7,500 Direct | · | Acquired | (price as of 2026-10-05) |
| Jan. 30, 2013 | GMED | A | 3,000 | · | · | 3,000 Direct | · | Acquired | (price as of 2026-10-05) |
| Aug. 29, 2012 | GMED | A | 1,500 | · | · | 1,500 Direct | · | Acquired | (price as of 2026-10-05) |
| Aug. 8, 2012 | GMED | J | 3,076 | · | · | 3,076 Direct | · | Acquired | (price as of 2026-10-05) |
| Aug. 8, 2012 | GMED | J | 3,076 | · | · | 3,076 Direct | · | Acquired | (price as of 2026-10-05) |
| Aug. 8, 2012 | GMED | J | 3,076 | · | · | 3,076 Direct | · | Acquired | (price as of 2026-10-05) |
| Aug. 8, 2012 | GMED | S | 2,305 | $11.16 | $25,724 | 20,771 Direct | -9.99% | Disposed | 578.9% (price as of 2026-10-05) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II) Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| Feb. 1, 2019 | GMED | Stock Option (Right to Buy Class A Common Stock) | Class A Common Stock | $43.87 | Feb. 1, 2029 | 7,500 | Acquired |
| Sept. 26, 2018 | GMED | Stock Option (Right to Buy Class A Common Stock) | Class A Common Stock | $12.59 | Jan. 30, 2023 | 3,000 | Disposed |
| Jan. 22, 2018 | GMED | Stock Option (Right to Buy Class A Common Stock) | Class A Common Stock | $43.77 | Jan. 22, 2028 | 7,500 | Acquired |
| Dec. 15, 2017 | GMED | Stock Option (Right to Buy Class A Common Stock) | Class A Common Stock | $4.88 | Aug. 6, 2019 | 3,076 | Disposed |
| Jan. 30, 2017 | GMED | Stock Option (Right to Buy Class A Common Stock) | Class A Common Stock | $26.27 | Jan. 30, 2027 | 7,500 | Acquired |
| May 28, 2015 | GMED | Stock Option (Right to Buy Class A Common Stock) | Class A Common Stock | $11.87 | June 16, 2020 | 3,076 | Disposed |
| Jan. 20, 2015 | GMED | Stock Option (Right to Buy Class A Common Stock) | Class A Common Stock | $24.10 | Jan. 20, 2025 | 22,500 | Acquired |
| Feb. 20, 2014 | GMED | Stock Option (Right to Buy Class A Common Stock) | Class A Common Stock | $23.57 | Feb. 20, 2024 | 7,500 | Acquired |
| Jan. 30, 2013 | GMED | Stock Option (Right to Buy Class A Common Stock) | Class A Common Stock | $12.59 | Jan. 30, 2023 | 3,000 | Acquired |
| Aug. 29, 2012 | GMED | Stock Option (Right to Buy Class A Common Stock) | Class A Common Stock | $15.34 | Aug. 29, 2022 | 1,500 | Acquired |
| Aug. 8, 2012 | GMED | Stock Option (Right to Buy Class A Common Stock) [F3] | Class A Common Stock [F3] | $10.66 | Oct. 27, 2021 | 3,076 | Acquired |
| Aug. 8, 2012 | GMED | Stock Option (Right to Buy Class A Common Stock) [F3] | Class A Common Stock [F3] | $11.87 | June 16, 2020 | 3,076 | Acquired |
| Aug. 8, 2012 | GMED | Stock Option (Right to Buy Class A Common Stock) [F3] | Class A Common Stock [F3] | $4.88 | Aug. 6, 2019 | 3,076 | Acquired |
Exercise/conversion price is blank when not applicable (e.g. RSUs).
Initial ownership (Form 3) 4 holdings
Securities held when first becoming an insider, per SEC Form 3.
| Date | Ticker | Security | Shares | Ownership |
|---|---|---|---|---|
| June 11, 2013 | GMED | Class A Common Stock | 23,076 | Direct |
| June 11, 2013 | GMED | Stock Option (Right to Buy Class C Common Stock) [F1] | 3,076 | Direct |
| June 11, 2013 | GMED | Stock Option (Right to Buy Class C Common Stock) [F1] | 3,076 | Direct |
| June 11, 2013 | GMED | Stock Option (Right to Buy Class C Common Stock) [F1] | 3,076 | Direct |